Skip to main content
SpringerLink
Log in

Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients?

  • Correspondence
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Carr RM, Patel A, Bownik H, et al. Intestinal inflammation does not predict nonalcoholic fatty liver disease severity in inflammatory bowel disease patients. Dig Dis Sci. 2017;5:1354–1361. doi:10.1007/s10620-017-4495-0.

    Article  Google Scholar 

  2. Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn’s disease. N Engl J Med. 2010;15:1383–1395.

    Article  Google Scholar 

  3. Woods CP, Hazlehurst JM, Tomlinson JW. Glucocorticoids and nonalcoholic fatty liver disease. J Steroid Biochem Mol Biol. 2015;154:94–103.

    Article  CAS  PubMed  Google Scholar 

  4. Bessissow T, Le NH, Rollet K, Afif W, Bitton A, Sebastiani G. Incidence and predictors of nonalcoholic fatty liver disease by serum biomarkers in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016;8:1937–1944.

    Article  Google Scholar 

  5. Brahmania M, Bernstein CN. Physician global assessments or blood tests do not predict mucosal healing in ulcerative colitis. Can J Gastroenterol Hepatol. 2014;6:325–329.

    Article  Google Scholar 

  6. Sipponen T, Kolho K-L. Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease. Scand J Gastroenterol. 2015;1:74–80.

    Article  Google Scholar 

  7. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5A–36A.

    Article  PubMed  Google Scholar 

  8. Lichtenstein GR, Hanauer SB, Sandborn WJ. Practice parameters Committee of American College of G. Management of Crohn’s disease in adults. Am J Gastroenterol. 2009;104:465–483.

    Article  PubMed  Google Scholar 

  9. Caliendo M, Kopeinig S. Some practical guidance for the implementation of propensity score matching. J Econ Surv. 2008;22:31–72.

    Article  Google Scholar 

  10. Thirumurthi S, Chowdhury R, Richardson P, Abraham NS. Validation of ICD-9-CM diagnostic codes for inflammatory bowel disease among veterans. Dig Dis Sci. 2010;55:2592–2598. doi:10.1007/s10620-009-1074-z.

    Article  PubMed  Google Scholar 

  11. Kramer JR, Davila JA, Miller ED, Richardson P, Giordano TP, El-Serag HB. The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Ther. 2008;27:274–282.

    Article  CAS  PubMed  Google Scholar 

  12. Kim D, Kim W, Kim HJ, Therneau TM. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology. 2013;57:1357–1365.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical and Surgical Sciences, University of Bologna, Via Albertoni, 15, 40100, Bologna, Italy

    Alessandro Sartini & Stefano Gitto

  2. Gastroenterology Unit, Department of Internal Medicine, University of Modena and Reggio Emilia, Modena, Italy

    Erica Villa

Authors
  1. Alessandro Sartini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stefano Gitto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Erica Villa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alessandro Sartini.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sartini, A., Gitto, S. & Villa, E. Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients?. Dig Dis Sci 62, 2604–2606 (2017). https://doi.org/10.1007/s10620-017-4665-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-017-4665-0

Search

Navigation